Table 1.

Clinical suggestions for patients who presented acute CV complication during acute COVID‐19

Cardiovascular complications diagnosed during acute COVID‐19	Specific suggestions that should integrate a complete clinical evaluation
If a clear diagnosis in relation with myocardial injury has been performed in the acute phase
Acute myocardial infarction type 1	Coronary angiography if not performed in the acute phase as soon as possible Check for CV risk factors and treat accordingly TTE
Acute myocardial infarction type 2	CCTA Identify and treat underlying causes Check for CV risk factors and treat accordingly TTE
Myocarditis	TTE at 3 months in clinically stable patients CRM if available at baseline or for differential diagnosis
Heart failure	TTE at 3 months in clinically stable patients Check for CV risk factors and treat accordingly
Arrhythmias	Check for correctable risk factors (e.g. drug‐associated prolonged QTc, such as hydroxychloroquine, and electrolyte disorders) Holter ECG and TTE as soon as possible
In persisting unexplained sinus tachycardia	Consider TTE
Pulmonary embolism	Check for temporary and permanent major and minor risk factor Check for thrombophilia in young patients or concomitant unusual site thrombosis TTE: check for pulmonary hypertension at 3 months or prior if symptoms

CCTA, coronary computed tomography angiography; COVID‐19, coronavirus disease 2019; CMR, cardiovascular magnetic resonance; CV, cardiovascular; ECG, electrocardiogram; TTE, transthoracic echocardiography.